EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Stereodivergent Synthesis of C5‐α‐Substituted Linezolid Derivatives From D ‐Mannitol and Structure–Antibacterial Activity Evaluation

José A Gálvez iD, Laura Sanz-Asensio, Ramón Badorrey iD, Jesús Gonzalo-Asensio iD

Chirality · 2026

DOI: 10.1002/chir.70138 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chirality, 2026. Verfasst von José A Gálvez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Química Orgánica, Instituto de Síntesis Química y Catálisis Homogénea (ISQCH), CSIC - Universidad de Zaragoza, Zaragoza, Spain. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Linezolid, Mannitol, Oxazolidinones. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Gobierno de Aragón.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A stereodivergent synthetic strategy enabling access to enantiopure C5‐α‐substituted linezolid analogues has been developed from D ‐mannitol as an inexpensive chiral pool precursor. The approach provides controlled access to both syn‐ and anti‐configured derivatives bearing ethyl or phenyl substituents at the α‐position of the C5 acetamidomethyl side chain, thereby introducing a second stereogenic center with high diastereocontrol. Key steps include highly selective nucleophilic additions of organometallic reagents to chiral N ‐benzyl imines derived from protected D‐glyceraldehyde and base‐promoted condensation of enantiopure N ‐Boc‐aminoepoxides with aryl carbamates to construct the 2‐oxazolidinone core. Comparative analysis of both configurational series revealed marked differences in cyclization efficiency, particularly for α‐phenyl‐substituted intermediates in the anti series, highlighting the steric sensitivity of oxazolidinone formation. In vitro assays against Gram‐positive and Mycobacterium spp. species showed complete loss of antibacterial activity for all α‐substituted derivatives, irrespective of configuration. These results establish a clear structural limitation at C5 and demonstrate that steric expansion at the α‐position overrides stereochemical effects. This study underscores the value of stereodivergent synthesis for rigorously disentangling configurational and substituent contributions in chiral bioactive scaffolds.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsLinezolidMannitolOxazolidinonesStereoisomerismStructure-Activity RelationshipMicrobial Sensitivity Tests

Stichwörter der Autor:innen

antimicrobials optimizationchiral poollinezolid analoguesoxazolidinonesstereoselective synthesisstructure–activity relationships

Substanzen

Anti-Bacterial AgentsLinezolidMannitolOxazolidinones

Autor:innen und Institutionen

  • Departamento de Química Orgánica, Instituto de Síntesis Química y Catálisis Homogénea (ISQCH), CSIC - Universidad de Zaragoza, Zaragoza, Spain.
  • Grupo de Genética de Micobacterias, Departamento de Microbiología, Facultad de Medicina, Universidad de Zaragoza, IIS Aragón, Zaragoza, Spain.
  • CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.

ORCID-Profile: José A Gálvez, Ramón Badorrey, Jesús Gonzalo-Asensio

Förderung

  • Gobierno de Aragón

Zitieren

APA

Gálvez, J. A., Sanz-Asensio, L., Badorrey, R., & Gonzalo-Asensio, J. (2026). Stereodivergent Synthesis of C5‐α‐Substituted Linezolid Derivatives From D ‐Mannitol and Structure–Antibacterial Activity Evaluation. Chirality. https://doi.org/10.1002/chir.70138

Vancouver

Gálvez JA, Sanz-Asensio L, Badorrey R, Gonzalo-Asensio J. Stereodivergent Synthesis of C5‐α‐Substituted Linezolid Derivatives From D ‐Mannitol and Structure–Antibacterial Activity Evaluation. Chirality. 2026. doi:10.1002/chir.70138

BibTeX
@article{Glvez2026,
  author = {Gálvez, José A and Sanz-Asensio, Laura and Badorrey, Ramón and Gonzalo-Asensio, Jesús},
  title = {Stereodivergent Synthesis of C5‐α‐Substituted Linezolid Derivatives From D ‐Mannitol and Structure–Antibacterial Activity Evaluation},
  journal = {Chirality},
  year = {2026},
  doi = {10.1002/chir.70138}
}
Kostenlos starten →